"CRISPR-Cas Offers Hope for HIV Cure by Cutting Virus from Infected Cells"

Scientists at the University of Amsterdam have developed a CRISPR-based gene editing process that shows promise in eliminating dormant HIV in cell samples, representing a potential step towards a cure strategy. While the technique is still in its early stages and its safety and effectiveness in living organisms remain uncertain, it has sparked hope for future HIV treatments. However, concerns about off-target effects and long-term side effects may slow down the progress of CRISPR-based therapy for HIV.